Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC-Norfolk prospective population-based cohort study.
Ria SanghaviTiberiu A PanaHulkar MamayusupovaIan D MaidmentChristopher FoxS Matthijs BoekholdtMamas Andreas MamasNicholas J WarehamKay-Tee KhawPhyo Kyaw MyintPublished in: British journal of clinical pharmacology (2022)
Higher ACB was associated with higher inflammatory markers. Inflammation may mediate the relationship between anticholinergic medications and adverse outcomes.
Keyphrases